Global Needle-free Injection Systems Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030

Global Needle-free Injection Systems Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030


Summary

According to APO Research, The global Needle-free Injection Systems market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

North American market for Needle-free Injection Systems is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Needle-free Injection Systems is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Needle-free Injection Systems is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Needle-free Injection Systems is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Needle-free Injection Systems include Antares Pharma, Endo International plc, Inovio Pharmaceuticals, Injex Pharma, National Medical Products Inc (J-Tip), Recipharm, European Pharma Group (InsuJet), Miracle Medical and Medical International Technology (MIT), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Needle-free Injection Systems, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Needle-free Injection Systems, also provides the sales of main regions and countries. Of the upcoming market potential for Needle-free Injection Systems, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Needle-free Injection Systems sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Needle-free Injection Systems market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Needle-free Injection Systems sales, projected growth trends, production technology, application and end-user industry.

Needle-free Injection Systems segment by Company

Antares Pharma
Endo International plc
Inovio Pharmaceuticals
Injex Pharma
National Medical Products Inc (J-Tip)
Recipharm
European Pharma Group (InsuJet)
Miracle Medical
Medical International Technology (MIT)
Akra Dermojet
PharmaJet
Portal Instruments
Crossject Medical Technology
MIKA MEDICAL
Ferring Pharmaceuticals
D'Antonio Consultants International
Lepu Medical
TECHiJET
Needle-free Injection Systems segment by Power
Reusable Injector
Single-use Injector
Needle-free Injection Systems segment by Application

Vaccine Delivery
Insulin Delivery
Others
Needle-free Injection Systems segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Needle-free Injection Systems status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Needle-free Injection Systems market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Needle-free Injection Systems significant trends, drivers, influence factors in global and regions.
6. To analyze Needle-free Injection Systems competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Needle-free Injection Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Needle-free Injection Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Needle-free Injection Systems.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Needle-free Injection Systems market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Needle-free Injection Systems industry.
Chapter 3: Detailed analysis of Needle-free Injection Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Needle-free Injection Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Needle-free Injection Systems in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Needle-free Injection Systems Sales Value (2019-2030)
1.2.2 Global Needle-free Injection Systems Sales Volume (2019-2030)
1.2.3 Global Needle-free Injection Systems Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Needle-free Injection Systems Market Dynamics
2.1 Needle-free Injection Systems Industry Trends
2.2 Needle-free Injection Systems Industry Drivers
2.3 Needle-free Injection Systems Industry Opportunities and Challenges
2.4 Needle-free Injection Systems Industry Restraints
3 Needle-free Injection Systems Market by Company
3.1 Global Needle-free Injection Systems Company Revenue Ranking in 2023
3.2 Global Needle-free Injection Systems Revenue by Company (2019-2024)
3.3 Global Needle-free Injection Systems Sales Volume by Company (2019-2024)
3.4 Global Needle-free Injection Systems Average Price by Company (2019-2024)
3.5 Global Needle-free Injection Systems Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Needle-free Injection Systems Company Manufacturing Base & Headquarters
3.7 Global Needle-free Injection Systems Company, Product Type & Application
3.8 Global Needle-free Injection Systems Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Needle-free Injection Systems Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Needle-free Injection Systems Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 Needle-free Injection Systems Market by Type
4.1 Needle-free Injection Systems Type Introduction
4.1.1 Reusable Injector
4.1.2 Single-use Injector
4.2 Global Needle-free Injection Systems Sales Volume by Type
4.2.1 Global Needle-free Injection Systems Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Needle-free Injection Systems Sales Volume by Type (2019-2030)
4.2.3 Global Needle-free Injection Systems Sales Volume Share by Type (2019-2030)
4.3 Global Needle-free Injection Systems Sales Value by Type
4.3.1 Global Needle-free Injection Systems Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Needle-free Injection Systems Sales Value by Type (2019-2030)
4.3.3 Global Needle-free Injection Systems Sales Value Share by Type (2019-2030)
5 Needle-free Injection Systems Market by Application
5.1 Needle-free Injection Systems Application Introduction
5.1.1 Vaccine Delivery
5.1.2 Insulin Delivery
5.1.3 Others
5.2 Global Needle-free Injection Systems Sales Volume by Application
5.2.1 Global Needle-free Injection Systems Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Needle-free Injection Systems Sales Volume by Application (2019-2030)
5.2.3 Global Needle-free Injection Systems Sales Volume Share by Application (2019-2030)
5.3 Global Needle-free Injection Systems Sales Value by Application
5.3.1 Global Needle-free Injection Systems Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Needle-free Injection Systems Sales Value by Application (2019-2030)
5.3.3 Global Needle-free Injection Systems Sales Value Share by Application (2019-2030)
6 Needle-free Injection Systems Market by Region
6.1 Global Needle-free Injection Systems Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Needle-free Injection Systems Sales by Region (2019-2030)
6.2.1 Global Needle-free Injection Systems Sales by Region: 2019-2024
6.2.2 Global Needle-free Injection Systems Sales by Region (2025-2030)
6.3 Global Needle-free Injection Systems Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Needle-free Injection Systems Sales Value by Region (2019-2030)
6.4.1 Global Needle-free Injection Systems Sales Value by Region: 2019-2024
6.4.2 Global Needle-free Injection Systems Sales Value by Region (2025-2030)
6.5 Global Needle-free Injection Systems Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Needle-free Injection Systems Sales Value (2019-2030)
6.6.2 North America Needle-free Injection Systems Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Needle-free Injection Systems Sales Value (2019-2030)
6.7.2 Europe Needle-free Injection Systems Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Needle-free Injection Systems Sales Value (2019-2030)
6.8.2 Asia-Pacific Needle-free Injection Systems Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Needle-free Injection Systems Sales Value (2019-2030)
6.9.2 Latin America Needle-free Injection Systems Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Needle-free Injection Systems Sales Value (2019-2030)
6.10.2 Middle East & Africa Needle-free Injection Systems Sales Value Share by Country, 2023 VS 2030
7 Needle-free Injection Systems Market by Country
7.1 Global Needle-free Injection Systems Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Needle-free Injection Systems Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Needle-free Injection Systems Sales by Country (2019-2030)
7.3.1 Global Needle-free Injection Systems Sales by Country (2019-2024)
7.3.2 Global Needle-free Injection Systems Sales by Country (2025-2030)
7.4 Global Needle-free Injection Systems Sales Value by Country (2019-2030)
7.4.1 Global Needle-free Injection Systems Sales Value by Country (2019-2024)
7.4.2 Global Needle-free Injection Systems Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Needle-free Injection Systems Sales Value Growth Rate (2019-2030)
7.5.2 Global Needle-free Injection Systems Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Needle-free Injection Systems Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Needle-free Injection Systems Sales Value Growth Rate (2019-2030)
7.6.2 Global Needle-free Injection Systems Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Needle-free Injection Systems Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Needle-free Injection Systems Sales Value Growth Rate (2019-2030)
7.7.2 Global Needle-free Injection Systems Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Needle-free Injection Systems Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Needle-free Injection Systems Sales Value Growth Rate (2019-2030)
7.8.2 Global Needle-free Injection Systems Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Needle-free Injection Systems Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Needle-free Injection Systems Sales Value Growth Rate (2019-2030)
7.9.2 Global Needle-free Injection Systems Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Needle-free Injection Systems Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Needle-free Injection Systems Sales Value Growth Rate (2019-2030)
7.10.2 Global Needle-free Injection Systems Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Needle-free Injection Systems Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Needle-free Injection Systems Sales Value Growth Rate (2019-2030)
7.11.2 Global Needle-free Injection Systems Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Needle-free Injection Systems Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Needle-free Injection Systems Sales Value Growth Rate (2019-2030)
7.12.2 Global Needle-free Injection Systems Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Needle-free Injection Systems Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Needle-free Injection Systems Sales Value Growth Rate (2019-2030)
7.13.2 Global Needle-free Injection Systems Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Needle-free Injection Systems Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Needle-free Injection Systems Sales Value Growth Rate (2019-2030)
7.14.2 Global Needle-free Injection Systems Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Needle-free Injection Systems Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Needle-free Injection Systems Sales Value Growth Rate (2019-2030)
7.15.2 Global Needle-free Injection Systems Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Needle-free Injection Systems Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Needle-free Injection Systems Sales Value Growth Rate (2019-2030)
7.16.2 Global Needle-free Injection Systems Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Needle-free Injection Systems Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Needle-free Injection Systems Sales Value Growth Rate (2019-2030)
7.17.2 Global Needle-free Injection Systems Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Needle-free Injection Systems Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Needle-free Injection Systems Sales Value Growth Rate (2019-2030)
7.18.2 Global Needle-free Injection Systems Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Needle-free Injection Systems Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Needle-free Injection Systems Sales Value Growth Rate (2019-2030)
7.19.2 Global Needle-free Injection Systems Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Needle-free Injection Systems Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Needle-free Injection Systems Sales Value Growth Rate (2019-2030)
7.20.2 Global Needle-free Injection Systems Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Needle-free Injection Systems Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Needle-free Injection Systems Sales Value Growth Rate (2019-2030)
7.21.2 Global Needle-free Injection Systems Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Needle-free Injection Systems Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Needle-free Injection Systems Sales Value Growth Rate (2019-2030)
7.22.2 Global Needle-free Injection Systems Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Needle-free Injection Systems Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Needle-free Injection Systems Sales Value Growth Rate (2019-2030)
7.23.2 Global Needle-free Injection Systems Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Needle-free Injection Systems Sales Value Share by Application, 2023 VS 2030
8 Company Profiles
8.1 Antares Pharma
8.1.1 Antares Pharma Comapny Information
8.1.2 Antares Pharma Business Overview
8.1.3 Antares Pharma Needle-free Injection Systems Sales, Value and Gross Margin (2019-2024)
8.1.4 Antares Pharma Needle-free Injection Systems Product Portfolio
8.1.5 Antares Pharma Recent Developments
8.2 Endo International plc
8.2.1 Endo International plc Comapny Information
8.2.2 Endo International plc Business Overview
8.2.3 Endo International plc Needle-free Injection Systems Sales, Value and Gross Margin (2019-2024)
8.2.4 Endo International plc Needle-free Injection Systems Product Portfolio
8.2.5 Endo International plc Recent Developments
8.3 Inovio Pharmaceuticals
8.3.1 Inovio Pharmaceuticals Comapny Information
8.3.2 Inovio Pharmaceuticals Business Overview
8.3.3 Inovio Pharmaceuticals Needle-free Injection Systems Sales, Value and Gross Margin (2019-2024)
8.3.4 Inovio Pharmaceuticals Needle-free Injection Systems Product Portfolio
8.3.5 Inovio Pharmaceuticals Recent Developments
8.4 Injex Pharma
8.4.1 Injex Pharma Comapny Information
8.4.2 Injex Pharma Business Overview
8.4.3 Injex Pharma Needle-free Injection Systems Sales, Value and Gross Margin (2019-2024)
8.4.4 Injex Pharma Needle-free Injection Systems Product Portfolio
8.4.5 Injex Pharma Recent Developments
8.5 National Medical Products Inc (J-Tip)
8.5.1 National Medical Products Inc (J-Tip) Comapny Information
8.5.2 National Medical Products Inc (J-Tip) Business Overview
8.5.3 National Medical Products Inc (J-Tip) Needle-free Injection Systems Sales, Value and Gross Margin (2019-2024)
8.5.4 National Medical Products Inc (J-Tip) Needle-free Injection Systems Product Portfolio
8.5.5 National Medical Products Inc (J-Tip) Recent Developments
8.6 Recipharm
8.6.1 Recipharm Comapny Information
8.6.2 Recipharm Business Overview
8.6.3 Recipharm Needle-free Injection Systems Sales, Value and Gross Margin (2019-2024)
8.6.4 Recipharm Needle-free Injection Systems Product Portfolio
8.6.5 Recipharm Recent Developments
8.7 European Pharma Group (InsuJet)
8.7.1 European Pharma Group (InsuJet) Comapny Information
8.7.2 European Pharma Group (InsuJet) Business Overview
8.7.3 European Pharma Group (InsuJet) Needle-free Injection Systems Sales, Value and Gross Margin (2019-2024)
8.7.4 European Pharma Group (InsuJet) Needle-free Injection Systems Product Portfolio
8.7.5 European Pharma Group (InsuJet) Recent Developments
8.8 Miracle Medical
8.8.1 Miracle Medical Comapny Information
8.8.2 Miracle Medical Business Overview
8.8.3 Miracle Medical Needle-free Injection Systems Sales, Value and Gross Margin (2019-2024)
8.8.4 Miracle Medical Needle-free Injection Systems Product Portfolio
8.8.5 Miracle Medical Recent Developments
8.9 Medical International Technology (MIT)
8.9.1 Medical International Technology (MIT) Comapny Information
8.9.2 Medical International Technology (MIT) Business Overview
8.9.3 Medical International Technology (MIT) Needle-free Injection Systems Sales, Value and Gross Margin (2019-2024)
8.9.4 Medical International Technology (MIT) Needle-free Injection Systems Product Portfolio
8.9.5 Medical International Technology (MIT) Recent Developments
8.10 Akra Dermojet
8.10.1 Akra Dermojet Comapny Information
8.10.2 Akra Dermojet Business Overview
8.10.3 Akra Dermojet Needle-free Injection Systems Sales, Value and Gross Margin (2019-2024)
8.10.4 Akra Dermojet Needle-free Injection Systems Product Portfolio
8.10.5 Akra Dermojet Recent Developments
8.11 PharmaJet
8.11.1 PharmaJet Comapny Information
8.11.2 PharmaJet Business Overview
8.11.3 PharmaJet Needle-free Injection Systems Sales, Value and Gross Margin (2019-2024)
8.11.4 PharmaJet Needle-free Injection Systems Product Portfolio
8.11.5 PharmaJet Recent Developments
8.12 Portal Instruments
8.12.1 Portal Instruments Comapny Information
8.12.2 Portal Instruments Business Overview
8.12.3 Portal Instruments Needle-free Injection Systems Sales, Value and Gross Margin (2019-2024)
8.12.4 Portal Instruments Needle-free Injection Systems Product Portfolio
8.12.5 Portal Instruments Recent Developments
8.13 Crossject Medical Technology
8.13.1 Crossject Medical Technology Comapny Information
8.13.2 Crossject Medical Technology Business Overview
8.13.3 Crossject Medical Technology Needle-free Injection Systems Sales, Value and Gross Margin (2019-2024)
8.13.4 Crossject Medical Technology Needle-free Injection Systems Product Portfolio
8.13.5 Crossject Medical Technology Recent Developments
8.14 MIKA MEDICAL
8.14.1 MIKA MEDICAL Comapny Information
8.14.2 MIKA MEDICAL Business Overview
8.14.3 MIKA MEDICAL Needle-free Injection Systems Sales, Value and Gross Margin (2019-2024)
8.14.4 MIKA MEDICAL Needle-free Injection Systems Product Portfolio
8.14.5 MIKA MEDICAL Recent Developments
8.15 Ferring Pharmaceuticals
8.15.1 Ferring Pharmaceuticals Comapny Information
8.15.2 Ferring Pharmaceuticals Business Overview
8.15.3 Ferring Pharmaceuticals Needle-free Injection Systems Sales, Value and Gross Margin (2019-2024)
8.15.4 Ferring Pharmaceuticals Needle-free Injection Systems Product Portfolio
8.15.5 Ferring Pharmaceuticals Recent Developments
8.16 D'Antonio Consultants International
8.16.1 D'Antonio Consultants International Comapny Information
8.16.2 D'Antonio Consultants International Business Overview
8.16.3 D'Antonio Consultants International Needle-free Injection Systems Sales, Value and Gross Margin (2019-2024)
8.16.4 D'Antonio Consultants International Needle-free Injection Systems Product Portfolio
8.16.5 D'Antonio Consultants International Recent Developments
8.17 Lepu Medical
8.17.1 Lepu Medical Comapny Information
8.17.2 Lepu Medical Business Overview
8.17.3 Lepu Medical Needle-free Injection Systems Sales, Value and Gross Margin (2019-2024)
8.17.4 Lepu Medical Needle-free Injection Systems Product Portfolio
8.17.5 Lepu Medical Recent Developments
8.18 TECHiJET
8.18.1 TECHiJET Comapny Information
8.18.2 TECHiJET Business Overview
8.18.3 TECHiJET Needle-free Injection Systems Sales, Value and Gross Margin (2019-2024)
8.18.4 TECHiJET Needle-free Injection Systems Product Portfolio
8.18.5 TECHiJET Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Needle-free Injection Systems Value Chain Analysis
9.1.1 Needle-free Injection Systems Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Needle-free Injection Systems Sales Mode & Process
9.2 Needle-free Injection Systems Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Needle-free Injection Systems Distributors
9.2.3 Needle-free Injection Systems Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings